71 – 80 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles
(
- Contribution to journal › Article
-
Mark
Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis
(
- Contribution to journal › Article
-
Mark
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
(
- Contribution to journal › Article
-
Mark
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
The European Vasculitis Society 2016 Meeting Report
(
- Contribution to journal › Article
-
Mark
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
(
- Contribution to journal › Article
- 2016
-
Mark
The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)
(
- Contribution to journal › Scientific review
-
Mark
Neutrophil extracellular traps in ANCA-associated vasculitis
(
- Contribution to journal › Scientific review